The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Open accessAbstract
While the catalog of mammalian transcripts and their expression levels in different cell types and disease states is rapidly expanding, our understanding of transcript function lags behind. We present a robust technology enabling systematic investigation of the cellular consequences of repressing or inducing individual transcripts. We identify rules for specific targeting of transcriptional repressors (CRISPRi), typically achieving 90%-99% knockdown with minimal off-target effects, and activators (CRISPRa) to endogenous genes via endonuclease-deficient Cas9. Together they enable modulation of gene expression over a ∼1,000-fold range. Using these rules, we construct genome-scale CRISPRi and CRISPRa libraries, each of which we validate with two pooled screens. Growth-based screens identify essential genes, tumor suppressors, and regulators of differentiation. Screens for sensitivity to a cholera-diphtheria toxin provide broad insights into the mechanisms of pathogen entry, retrotranslocation and toxicity. Our results establish CRISPRi and CRISPRa as powerful tools that provide rich and complementary information for mapping complex pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with gain-of-function perturbations, a higher proportion of loss-of-function perturbations yield phenotypes in growth and chemical-genetic screens, especially for members of protein complexes (Gilbert et al., 2014; Horlbeck et al., 2016).”
From Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq (2022) · cites this paper as Gilbert et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, CRISPRi (interference)23–25 and CRISPRa (activation)26–30 technologies utilize catalytically inactive Cas9 (dCas9) fused to either a transcriptional repressor (e.g., KRAB, Krüppel associated box) or a transcriptional activator (e.g., VPR, VP64-p65-Rta).”
From Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions (2025) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“Pooling gene perturbations greatly improves scalability, but is not compatible with imaging of complex and dynamic cellular phenotypes.”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Gilbert et al., 2014
In the citing paper
“Striking examples are familial mutations causing neurodegenerative diseases, such as hereditary motor and sensory neuropathies (Charcot-Marie-Tooth disease), which can be caused by mutations in ubiquitously expressed trafficking factors (RAB7A, DNM2, DYNC1H1), or aminoacyl-tRNA synthetases (AARS, GARS, HARS, MARS)2.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [2]
In the citing paper
“In addition to gene expression, gene function can also be cell type-specific, as evidenced by the fact that mutations in broadly expressed or housekeeping genes can lead to cell-type specific defects and disease states.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [2]
In the citing paper
“CRISPRa evaluates gain-of-function phenotypes and can provide complementary insight to CRISPR knockout or CRISPRi-based loss-of-function screens42.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [42]
In the citing paper
“CRISPRi-based gene knockdown may result in weaker phenotypes than full gene knockout, however it is non-toxic in iPSCs and iPSC-derived cells76, inducible76 and reversible42, thereby enabling time-resolved analysis of gene function76.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [42]
In the citing paper
“CRISPRi represents an important advance over RNAi, since it lacks the pervasive off-target effects (Gilbert et al., 2014) inherent to RNAi-based screening approaches (Adamson et al., 2012; Jackson et al., 2003; Kaelin, 2012).”
From CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons (2019) · cites this paper as Gilbert et al., 2014
In the citing paper
“Second, it is inducible and reversible (Gilbert et al., 2014)”
From CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons (2019) · cites this paper as Gilbert et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
Derrien, T., Johnson, R., Bussotti, G., Andrea Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D. G., et al. (2012) · Genome Research · doi:10.1101/gr.132159.111 · Cited by 5,135
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,008
Noorani, I. (2019) · Cancers · doi:10.3390/cancers11091335 · Cited by 45
An Improved CRISPR/dCas9 Interference Tool for Neuronal Gene Suppression
Duke, C. G., Bach, S. V., Revanna, J. S., Sultan, F. A., Southern, N. T., Davis, M. N., Carullo, N. V. N., Bauman, A. J., Phillips, R. A., & Day, J. J. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.00009 · Cited by 40
Eptaminitaki, G. C., Wolff, N. S., Stellas, D., Sifakis, K., & Baritaki, S. (2021) · Cells · doi:10.3390/cells10123313 · Cited by 44
Wang, J., Chen, C., Wang, L., Xie, M., Ge, X., Wu, S., He, Y., Mou, X., Ye, C., & Sun, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.872531 · Cited by 46
An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus
Navickas, A., Asgharian, H., Winkler, J., Fish, L., Garcia, K., Markett, D., Dodel, M., Culbertson, B., Miglani, S., Joshi, T. V., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01141-9 · Cited by 43
Enhanced Cas12a multi-gene regulation using a CRISPR array separator
Magnusson, J. P., Rios, A., Wu, L., & Qi, L. S. (2021) · eLife · doi:10.7554/elife.66406 · Cited by 45
Self-citationCRISPR-Cas System: The Current and Emerging Translational Landscape
Bhokisham, N., Laudermilch, E., Traeger, L. L., Bonilla, T. D., Ruíz-Estévez, M., & Becker, J. R. (2023) · Cells · doi:10.3390/cells12081103 · Cited by 46
An automated microfluidic gene-editing platform for deciphering cancer genes
Sinha, H., Quach, A. B. V., Vo, P. Q. N., & Shih, S. C. C. (2018) · Lab on a Chip · doi:10.1039/c8lc00470f · Cited by 44
Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming
Krawczyk, K., Scheller, L., Kim, H., & Fussenegger, M. (2020) · Nature Communications · doi:10.1038/s41467-020-14397-8 · Cited by 43
High-throughput bacterial functional genomics in the sequencing era
Gray, A. N., Koo, B., Shiver, A. L., Peters, J. M., Osadnik, H., & Gross, C. A. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.07.012 · Cited by 40
IFITM proteins assist cellular uptake of diverse linked chemotypes
Lou, K., Wassarman, D. R., Yang, T., Paung, Y., Zhang, Z., O’Loughlin, T. A., Moore, M. K., Egan, R. K., Greninger, P., Benes, C. H., et al. (2022) · Science · doi:10.1126/science.abl5829 · Cited by 42
Self-citationCRISPR-Based Genome Editing: Advancements and Opportunities for Rice Improvement
Zegeye, W. A., Tsegaw, M., Zhang, Y., & Cao, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084454 · Cited by 49
Zhang, W., Zhang, M., Xu, Z., Yan, H., Wang, H., Jiang, J., Wan, J., Tang, B., Liu, C., Chen, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40861-2 · Cited by 46
CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy
Ding, S., Liu, J., Han, X., & Tang, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216325 · Cited by 51
CRISPR /Cas9‐based editing of NF‐YC4 promoters yields high‐protein rice and soybean
Wang, L., O’Conner, S., Tanvir, R., Zheng, W., Cothron, S., Towery, K., Bi, H., Ellison, E. E., Yang, B., Voytas, D. F., et al. (2024) · New Phytologist · doi:10.1111/nph.20141 · Cited by 45
Comprehensive transcription factor perturbations recapitulate fibroblast transcriptional states
Southard, K. M., Ardy, R. C., Tang, A., O'Sullivan, D., Metzner, E., Guruvayurappan, K., & Norman, T. M. (2025) · Nature Genetics · doi:10.1038/s41588-025-02284-1 · Cited by 46
LncRNAs in vertebrates: Advances and challenges
Mallory, A. C., & Shkumatava, A. (2015) · Biochimie · doi:10.1016/j.biochi.2015.03.014 · Cited by 46
Using CRISPR/Cas to study gene function and model disease in vivo
Tschaharganeh, D. F., Lowe, S. W., Garippa, R. J., & Livshits, G. (2016) · FEBS Journal · doi:10.1111/febs.13750 · Cited by 47
Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
Kießling, M. K., Schuierer, S., Stertz, S., Beibel, M., Bergling, S., Knehr, J., Carbone, W., de Vallière, C., Tchinda, J., Bouwmeester, T., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-3042-2 · Cited by 49
CRISPR-Mediated Epigenome Editing.
Enríquez, P. (2016) · Europe PMC (PubMed Central) · Cited by 41
Bidirectional manipulation of gene expression in adipocytes using CRISPRa and siRNA
Lundh, M., Plucińska, K., Isidor, M. S., Petersen, P. S. S., & Emanuelli, B. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.001 · Cited by 42
New tools for old drugs: Functional genetic screens to optimize current chemotherapy
Gerhards, N. M., & Rottenberg, S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.01.001 · Cited by 43
Temporal and Spatial Epigenome Editing Allows Precise Gene Regulation in Mammalian Cells
Kuscu, C., Mammadov, R., Czikora, Á., Unlu, H., Tufan, T., Fischer, N. L., Arslan, Ş., Bekiranov, S., Kanemaki, M. T., & Adli, M. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.08.001 · Cited by 42
Genome-Wide CRISPRi-Based Identification of Targets for Decoupling Growth from Production
Li, S., Jendresen, C. B., Landberg, J., Pedersen, L. E., Sonnenschein, N., Jensen, S. I., & Nielsen, A. T. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00143 · Cited by 39
Automated 3D light-sheet screening with high spatiotemporal resolution reveals mitotic phenotypes
Eismann, B., Krieger, T. G., Beneke, J., Bulkescher, R., Adam, L., Erfle, H., Herrmann, C., Eils, R., & Conrad, C. (2020) · Journal of Cell Science · doi:10.1242/jcs.245043 · Cited by 42
Systematic in vitro profiling of off-target affinity, cleavage and efficiency for CRISPR enzymes
Zhang, L., Rube, H. T., Vakulskas, C. A., Behlke, M. A., Bussemaker, H. J., & Pufall, M. A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa231 · Cited by 45
Fernandes, L. G. V., Hornsby, R. L., Nascimento, A. L. T. O., & Nally, J. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-81400-7 · Cited by 42
A genome-scale CRISPR interference guide library enables comprehensive phenotypic profiling in yeast
McGlincy, N. J., Meacham, Z. A., Reynaud, K., Muller, R. Y., Baum, R., & Ingolia, N. T. (2021) · BMC Genomics · doi:10.1186/s12864-021-07518-0 · Cited by 47
Vasseur, M. L., Friedman, J. R., Jost, M., Xu, J., Yamada, J., Kampmann, M., Horlbeck, M. A., Salemi, M., Phinney, B. S., Weissman, J. S., et al. (2021) · eLife · doi:10.7554/elife.67624 · Cited by 41
Self-citationGenome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414
Self-citationConversion of embryonic stem cells into extraembryonic lineages by CRISPR-mediated activators
Wei, S. H., Zou, Q., Lai, S., Zhang, Q., Li, L., Yan, Q., Zhou, X., Zhong, H., & Lai, L. (2016) · Scientific Reports · doi:10.1038/srep19648 · Cited by 41
TSSC1 is novel component of the endosomal retrieval machinery
Gershlick, D. C., Schindler, C., Chen, Y., & Bonifacino, J. S. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-04-0209 · Cited by 40
Self-citationMechanisms of Long Non-Coding RNAs in the Assembly and Plasticity of Neural Circuitry
Wang, A., Wang, J., Liu, Y., & Zhou, Y. (2017) · Frontiers in Neural Circuits · doi:10.3389/fncir.2017.00076 · Cited by 42
CRISPR RNA-guided autonomous delivery of Cas9
Wilkinson, R. A., Martin, C. D., Nemudryi, A. A., & Wiedenheft, B. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0173-y · Cited by 43
CRISPR screen in mechanism and target discovery for cancer immunotherapy
Liu, D., Zhao, X., Tang, A., Xu, X., Liu, S., Zha, L., Ma, W., Zheng, J., & Shi, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188378 · Cited by 44
Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice
Tolani, B., Celli, A., Yao, Y., Tan, Y. Z., Fetter, R. D., Liem, C. R., de Smith, A. J., Vasanthakumar, T., Bisignano, P., Cotton, A. D., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01386-z · Cited by 44
Self-citationA benchmarked, high-efficiency prime editing platform for multiplexed dropout screening
Cirincione, A., Simpson, D., Yan, W., McNulty, R., Ravisankar, P., Solley, S. C., Yan, J., Lim, F., Farley, E. K., Singh, M., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02502-4 · Cited by 42
Self-citationShen, H. M., McHale, C. M., Smith, M. T., & Zhang, L. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.01.002 · Cited by 40
CRISPR‐Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies
Wen, W., Yuan, Z., Ma, S., Jiang, X., & Yuan, D. (2015) · International Journal of Cancer · doi:10.1002/ijc.29626 · Cited by 41
CRISPR-Cas9: from Genome Editing to Cancer Research
Chen, S., Sun, H., Miao, K., & Deng, C. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.17421 · Cited by 40
Krupkova, O., Cambria, E., Bešše, L., Bešše, A., Bowles, R., & Wuertz‐Kozak, K. (2018) · JOR Spine · doi:10.1002/jsp2.1003 · Cited by 40
Yeast genetic interaction screens in the age of CRISPR/Cas
Adames, N. R., Gallegos, J. E., & Peccoud, J. (2018) · Current Genetics · doi:10.1007/s00294-018-0887-8 · Cited by 36
Blanas, A., Cornelissen, L. A. M., Kotsias, M., van der Horst, J. C., van de Vrugt, H. J., Kalay, H., Spencer, D. I. R., Kozak, R. P., & van Vliet, S. J. (2018) · Glycobiology · doi:10.1093/glycob/cwy096 · Cited by 39
Awakening dormant glycosyltransferases in CHO cells with CRISPRa
Karottki, K. J. L. C., Hefzi, H., Xiong, K., Shamie, I., Hansen, A. H., Li, S., Pedersen, L. E., Li, S., Lee, J. S., Lee, G. M., et al. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27199 · Cited by 40
Klotho and the Treatment of Human Malignancies
Sachdeva, A., Gouge, J., Kontovounisios, C., Nikolaou, S., Ashworth, A., Lim, K. J., & Chong, I. Y.-S. (2020) · Cancers · doi:10.3390/cancers12061665 · Cited by 41
Defining the ATPome reveals cross-optimization of metabolic pathways
Bennett, N. K., Nguyen, M. K., Darch, M. A., Nakaoka, H. J., Cousineau, D., ten Hoeve, J., Graeber, T. G., Schuelke, M., Maltepe, E., Kampmann, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18084-6 · Cited by 40
Self-citationPhotocontrol of CRISPR/Cas9 function by site-specific chemical modification of guide RNA
Wang, Y., Liu, Y., Xie, F., Lin, J., & Xu, L. (2020) · Chemical Science · doi:10.1039/d0sc04343e · Cited by 40
Genome engineering of stem cell organoids for disease modeling
Sun, Y., & Ding, Q. (2017) · Protein & Cell · doi:10.1007/s13238-016-0368-0 · Cited by 39
Lattke, M., & Guillemot, F. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1557 · Cited by 45
Liu, Z., Wu, T., Xiang, G., Wang, H., Wang, B., Zheng, F., Mu, Y., & Li, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137331 · Cited by 44
Histone malonylation is regulated by SIRT5 and KAT2A
Zhang, R., Bons, J., Scheidemantle, G. M., Liu, X., Bielska, O., Carrico, C., Rose, J., Heckenbach, I., Scheibye‐Knudsen, M., Schilling, B., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106193 · Cited by 40
Mahato, R. K., Bhattacharya, S., Khullar, N., Sidhu, I. S., Reddy, P. H., Bhatti, G. K., & Bhatti, J. S. (2023) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2023.12.003 · Cited by 40
Building CRISPR Gene Therapies for the Central Nervous System
Salomonsson, S. E., & Clelland, C. D. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2023.4983 · Cited by 42
Chen, Y.-C., Farzadfard, F., Gharaei, N., Chen, W. C. W., Cao, J., & Lu, T. K. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.014 · Cited by 39
Self-citationCRISPR History: Discovery, Characterization, and Prosperity
Han, W., & She, Q. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.10.001 · Cited by 43
Nayak, S., Aich, M., Kumar, A., Sengupta, S., Bajad, P., Dhapola, P., Paul, D., Narta, K., Purkrait, S., Mehani, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26000-8 · Cited by 39
SOX4 regulates invasion of bladder cancer cells via repression of WNT5a
Moran, J. D., Kim, H., Li, Z., & Moreno, C. S. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4832 · Cited by 39
Miyahira, A. K., Sharp, A., Ellis, L., Jones, J. C., Kaochar, S., Larman, H. B., Quigley, D. A., Ye, H., Simons, J. W., Pienta, K. J., et al. (2019) · The Prostate · doi:10.1002/pros.23934 · Cited by 40
A Tale of Two Moieties: Rapidly Evolving CRISPR/Cas-Based Genome Editing
Yang, L. C., & Chen, J. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.06.003 · Cited by 38
multicrispr: gRNA design for prime editing and parallel targeting of thousands of targets
Bhagwat, A. M., Graumann, J., Wiegandt, R., Bentsen, M. S., Welker, J. M., Kuenne, C. T., Preussner, J., Braun, T. W., & Looso, M. (2020) · Life Science Alliance · doi:10.26508/lsa.202000757 · Cited by 39
Chen, Y.-C., Kuo, P., Chou, Y., Chong, H., Hsieh, Y.-T., Yang, M.-L., Wu, C., Shiau, A., & Wang, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010301 · Cited by 39
Self-citationThe role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis
Peng, P., Hsu, K., Lai, J. C., & Wu, K. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.03.005 · Cited by 40
Das, R., Sjöström, M., Shrestha, R., Yogodzinski, C., Egusa, E. A., Chesner, L. N., Chen, W. S., Chou, J., Dang, D. K., Swinderman, J. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24919-7 · Cited by 38
Self-citationGoel, K., & Ploski, J. E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.914430 · Cited by 41
An inducible CRISPR activation tool for accelerating plant regeneration
Zhang, C., Tang, Y., Tang, S., Chen, L., Li, T., Yuan, H., Xu, Y., Zhou, Y., Zhang, S., Wang, J., et al. (2024) · Plant Communications · doi:10.1016/j.xplc.2024.100823 · Cited by 38
Musunuru, K. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.002 · Cited by 38
Applications of Lgr5-Positive Cochlear Progenitors (LCPs) to the Study of Hair Cell Differentiation
Lenz, D. R., Gunewardene, N., Abdul‐Aziz, D., Wang, Q., Gibson, T. M., & Edge, A. S. B. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00014 · Cited by 38
Modeling genetic epilepsies in a dish
Niu, W., & Parent, J. M. (2019) · Developmental Dynamics · doi:10.1002/dvdy.79 · Cited by 38
Heat-Triggered Remote Control of CRISPR-dCas9 for Tunable Transcriptional Modulation
Gamboa, L., Phung, E. V., Li, H., Meyers, J. P., Hart, A. C., Miller, I. C., & Kwong, G. A. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b01005 · Cited by 36
CRISPR/Cas9 Technology: Applications and Human Disease Modeling
Martínez-Lage, M., Torres-Ruiz, R., & Rodríguez, S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.09.002 · Cited by 40
Synthetic immunomodulation with a CRISPR super-repressor in vivo
Moghadam, F., LeGraw, R., Velazquez, J. J., Yeo, N. C., Xu, C., Park, J. H., Chavez, A., Ebrahimkhani, M. R., & Kiani, S. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0563-3 · Cited by 38
Huang, D., Miller, M., Ashok, B., Jain, S., & Peppas, N. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.015 · Cited by 38
Schwartz, J. L., Jones, K. L., & Yeo, G. W.-M. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1841726 · Cited by 36
A metabolic CRISPR-Cas9 screen in Chinese hamster ovary cells identifies glutamine-sensitive genes
Karottki, K. J. L. C., Hefzi, H., Li, S., Pedersen, L. E., Spahn, P. N., Joshi, C. J., Ruckerbauer, D. E., Bort, J. A. H., Thomas, A., Lee, J. S., et al. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2021.03.017 · Cited by 37
Functional annotation of lncRNA in high-throughput screening
Yip, C. W., Sivaraman, D. M., Prabhu, A. V., & Shin, J. W. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200061 · Cited by 37
Ke, J., Robinson, D., Wu, Z., Kuftin, A., Louie, K., Kosina, S. M., Northen, T. R., Cheng, J., & Yoshikuni, Y. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.08.009 · Cited by 37
SOX9 maintains human foetal lung tip progenitor state by enhancing WNT and RTK signalling
Sun, D., Llora Batlle, O., van den Ameele, J., Thomas, J. C., He, P., Lim, K., Tang, W., Xu, C., Meyer, K. B., Teichmann, S. A., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022111338 · Cited by 38
Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenograftsPreprint
Quinn, J. J., Jones, M. G., Okimoto, R. A., Nanjo, S., Chan, M. M., Yosef, N., Bivona, T. G., & Weissman, J. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.16.045245 · Cited by 38
Self-citationLo, Y.-H., Horn, H. T., Huang, M.-F., Yu, W.-C., Young, C.-M., Liu, Q., Tomaske, M., Towers, M., Dominguez, A., Bassik, M. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62818-3 · Cited by 37
“…were calculated by calculating the log2 change in the enrichment of a sgRNA in the treated and untreated samples, subtracting the equivalent median value for all non-targeting sgRNAs, and dividing by the number of population doubling differences between the treated and untreated populations 28 .”
Self-citationInterphotoreceptor Retinoid-Binding Protein (IRBP) in Retinal Health and Disease
Zeng, S., Zhang, T., Madigan, M. C., Fernando, N., Aggio-Bruce, R., Zhou, F., Pierce, M., Chen, Y., Huang, L., Natoli, R., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.577935 · Cited by 37
Self-citationGenome-scale CRISPRi screening: A powerful tool in engineering microbiology
Sun, L., Zheng, P., Sun, J., Wendisch, V. F., & Wang, Y. (2023) · Engineering Microbiology · doi:10.1016/j.engmic.2023.100089 · Cited by 35
Applications of CRISPR-Cas9 mediated genome engineering
Yang, X. P. (2015) · Military Medical Research · doi:10.1186/s40779-015-0038-1 · Cited by 38
Use of CRISPR/Cas9 for Symbiotic Nitrogen Fixation Research in Legumes
Wang, L., Wang, L., Zhou, Y., & Duanmu, D. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.03.010 · Cited by 38
CRISPR‐Enabled Tools for Engineering Microbial Genomes and Phenotypes
Tarasava, K., Oh, E. J., Eckert, C. A., & Gill, R. T. (2018) · Biotechnology Journal · doi:10.1002/biot.201700586 · Cited by 37
Li, J., Huang, C., Xiong, T., Zhuang, C., Zhuang, C., Li, Y., Ye, J., & Gui, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.32332 · Cited by 37
Amirkhah, R., Naderi‐Meshkin, H., Shah, J. S., Dunne, P. D., & Schmitz, U. (2019) · Cells · doi:10.3390/cells8080929 · Cited by 41
New factors for protein transport identified by a genome-wide CRISPRi screen in mammalian cells
Bassaganyas, L., Popa, S. J., Horlbeck, M. A., Puri, C., Stewart, S. E., Campelo, F., Ashok, A., Butnaru, C. M., Brouwers, N., Heydari, K., et al. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201902028 · Cited by 36
Self-citationUnderstanding and Engineering Chromatin as a Dynamical System across Length and Timescales
Johnstone, C. P., Wang, N., Sevier, S. A., & Galloway, K. E. (2020) · Cell Systems · doi:10.1016/j.cels.2020.09.011 · Cited by 36
Guide-target mismatch effects on dCas9–sgRNA binding activity in living bacterial cells
Feng, H., Guo, J., Wang, T., Zhang, C., & Xing, X. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1295 · Cited by 38
Efficient multiplexed gene regulation inSaccharomyces cerevisiaeusing dCas12a
Ciurkot, K., Gorochowski, T. E., Roubos, J. A., & Verwaal, R. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab529 · Cited by 37
Extracellular vesicles from neurons promote neural induction of stem cells through cyclin D1
Song, L., Tian, X., & Schekman, R. W. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202101075 · Cited by 34
Sevastre, A.-S., Costachi, A., Tătăranu, L. G., Brandusa, C., Artene, Ş.-A., Stovicek, P. O., Alexandru, O., Dănoiu, S., Sfredel, V., & Dricu, A. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10844 · Cited by 40
Correction of Monogenic and Common Retinal Disorders with Gene Therapy
Sengillo, J. D., Justus, S., Cabral, T., & Tsang, S. H. (2017) · Genes · doi:10.3390/genes8020053 · Cited by 39
Identifying oligodendrocyte enhancers governing Plp1 expression
Kim, D., An, H., Fan, C., & Park, Y. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab184 · Cited by 39
EpiCas-DL : Predicting sgRNA activity for CRISPR-mediated epigenome editing by deep learning
Yang, Q., Wu, L., Meng, J., Ma, L., Zuo, E., & Sun, Y. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.11.034 · Cited by 37
CRISPR-array-mediated imaging of non-repetitive and multiplex genomic loci in living cells
Yang, L.-Z., Min, Y.-H., Liu, Y., Gao, B., Liu, X.-Q., Huang, Y., Wang, H., Yang, L. C., Liu, Z. J., & Chen, L. (2024) · Nature Methods · doi:10.1038/s41592-024-02333-3 · Cited by 36
High-Throughput Silencing Using the CRISPR-Cas9 System: A Review of the Benefits and Challenges
Wade, M. R. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115587916 · Cited by 39
Jo, Y.-I., Suresh, B., Kim, S., & Ramakrishna, S. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.09.003 · Cited by 36
Functional Genomic Strategies for Elucidating Human–Virus Interactions
Perreira, J. M., Meraner, P., & Brass, A. L. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2015.11.001 · Cited by 39
The expanding footprint of CRISPR/Cas9 in the plant sciences
Schaeffer, S. M., & Nakata, P. A. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1987-x · Cited by 37
Metadata
- Authors
- Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., Qi, L. S., Kampmann, M., & Weissman, J. S.
- Affiliations
- QB3 (US)
- University of California, San Francisco (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Kampmann, Martin
- Weissman, Jonathan S.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 159
- Issue
- 3
- Pages
- 647-661
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4253859
- OpenAlex
- W2152505144
- Cited by
- 2,728
- References
- 60
- Citations by year
- 2026: 190 · 2025: 211 · 2024: 265 · 2023: 212 · 2022: 261 · 2021: 285 · 2020: 285 · 2019: 255 · 2018: 221 · 2017: 214 · 2016: 182 · 2015: 125 · 2014: 14
- FWCI
- 73.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (DP5OD017887, 1dp2hd084069-01)
- National Institute on Aging (P01AG010770)
- National Institute on Drug Abuse (R01DA036858)
- National Cancer Institute (K99CA181494, U01CA168370)
- National Institute of General Medical Sciences (T32GM008284, P50GM081879, R01GM100341, P50GM102706, R01GM100518)
- National Institute of Biomedical Imaging and Bioengineering (T32EB009383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR interference, CRISPR activation, transcriptional repression, transcriptional activation, gene essentiality, tumor suppressor, cholera toxin, diphtheria toxin, pathogen entry, retrotranslocation, off-target effects
- MeSH terms
- Cell Line, Cholera Toxin, Diphtheria Toxin, Genetic Techniques, Humans, Transcription, Genetic, Genome, Human, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
